1 차 척수 손상 재활에서 표준 강도 훈련에 비해 편심의 영향 (KREHA3)
1 차 척수 손상 재활에서 표준 강도 훈련에 비해 편심의 영향 - 일치하는 쌍의 무작위 대조 시험 시험
The goal of this clinical trial is to assess the effects of eccentric arm-crank (KREHA) training compared to standard clinical routine strength (STAN) training in individuals undergoing primary spinal cord injury (SCI) rehabilitation.
The main questions this trail aims to answer are:
- what are the effects of the training on upper body strength, aerobic performance, muscle volume, functional independence, and health-related quality of life?
- is the KREHA training feasible to implement into the rehabilitation routine?
Participants will:
- perform either 20 KREHA sessions or 20 STAN sessions within 12 weeks
- perform a test battery to collect data on training effects before (pretest) and after (posttest) the study intervention
연구 개요
상태
상태
정황
정황
개입 / 치료
개입 / 치료
연구 유형
연구 유형
등록 (추정된)
등록
단계
단계
- 해당 없음
연락처 및 위치
연구 연락처
연구 연락처
- 이름: Fabian Ammann, MSc
- 전화번호: +41419396624
- 이메일: fabian.ammann@paraplegie.ch
연구 연락처 백업
- 이름: Anneke Hertig-Godeschalk, PhD
- 전화번호: +414 9396603
- 이메일: anneke.hertig@paraplegie.ch
연구 장소
-
-
Canton of Lucerne
-
Nottwil, Canton of Lucerne, 스위스, 6207
- Swiss Paraplegic Centre
-
-
참여기준
자격 기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
설명
Inclusion Criteria:
- 18 years or older.
- informed consent as confirmed per signature.
- traumatic or disease-related SCI.
- participating in the routine strength training program during primary SCI rehabilitation at the study center (generally this is initiated around one month after SCI onset).
- wheelchair dependency during activities of daily living, defined by a score of 0-2 in the SCIM subsection regarding "Mobility in the house".
- passed sports medical assessment and having sufficient biceps/triceps function to perform arm-crank training, as determined by an experienced sports medicine physician
Exclusion Criteria:
- inflammatory or neurodegenerative diseases (including multiple sclerosis or Guillain-Barré syndrome).
- comorbidities or other health issues that may interfere with study participation, inability or contraindications to undergo the investigated intervention.
- MRI contraindications (magnetic metal parts or electronic implants such as pacemakers in the body).
- pregnancy (anamnestic).
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 지지 요법
- 할당: 무작위
- 중재 모델: 병렬 할당
- 마스킹: 없음(오픈 라벨)
팔의 수
무기와 개입
참가자 그룹 / 팔참가자 그룹 / 팔 |
개입 / 치료개입 / 치료 |
|---|---|
|
실험적: Eccentric arm-crank (KREHA) training
The eccentric training intervention consists of 20 training sessions performed on a symmetric arm-crank (Krafttraining mittels exzentrischer Handkurbel, KREHA) device. The training sessions have a duration of approximately 30 min and will be completed within twelve weeks, with a maximum of three sessions per week. |
20 eccentric resistance training sessions will be performed on a symmetric arm-crank ergometer in a supine position. |
|
활성 비교기: Standard clinical routine strength (STAN) training
The standard strength training intervention consists of a total of 20 training sessions at the gym of the study center, performed following clinical routine procedures. The training sessions have a duration of approximately 60 min and will be completed within twelve weeks, with around three sessions per week. |
The regular strength training intervention consists of a total of 20 training sessions at the gym of the study center, performed following clinical routine procedures. |
연구는 무엇을 측정합니까?
주요 결과 측정
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Upper body strength
기간: < 1 week pre and 12 weeks post intervention start.
|
Change in upper body strength will be measured by a one-repetition maximum (1RM) bench press (in kg). The maximum amount of weight that can be pushed upwards for one repetition, while lying in a supine position on a weight training bench. |
< 1 week pre and 12 weeks post intervention start.
|
2차 결과 측정
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Upper body strength
기간: < 1 week pre and 12 weeks post intervention start.
|
Change in upper body strength measured by a 1RM bench pull (in kg). The maximum amount of weight that can be pulled upwards for one repetition, while lying in a prone position on a weight training bench. |
< 1 week pre and 12 weeks post intervention start.
|
|
Handgrip strength
기간: < 1 week pre and 12 weeks post intervention start.
|
Change in maximum strength of three handgrip measurements (in kg) of both hands using a Jamar Handgrip Dynamometer. |
< 1 week pre and 12 weeks post intervention start.
|
|
Aerobic performance
기간: < 1 week pre and 12 weeks post intervention start.
|
Change in cardiopulmonary adaptations, measured by aerobic performance in an exercise test on a regular arm-crank ergometer. A ramp protocol starting at 20 Watt followed by 1 Watt / 6 sec increments to failure will be used. The following parameters will be evaluated during this aerobic endurance test: power at failure at the end of the test (in Watt), peak oxygen uptake during the test (in ml/kg/min), maximal heart rate (bpm) |
< 1 week pre and 12 weeks post intervention start.
|
|
Muscle volume
기간: < 1 week pre and 12 weeks post intervention start.
|
Magnetic resonance imaging (MRI) of relevant upper body muscles of the dominant upper arm and shoulder will be used to measure change in muscle volume. |
< 1 week pre and 12 weeks post intervention start.
|
|
Arm circumference
기간: < 1 week pre and 12 weeks post intervention start.
|
Change in arm circumference of the right and left lower and upper arm (in cm), will be used to estimate muscle volume. |
< 1 week pre and 12 weeks post intervention start.
|
|
Functioning during activities of daily living
기간: < 1 week pre and 12 weeks post intervention start.
|
Change in functioning during activities of daily living will be assessed by the Spinal Cord Independence Measure (SCIM) as extracted from clinical records. The SCIM total score ranges from 0-100, with higher scores indicating higher levels of functional independence. |
< 1 week pre and 12 weeks post intervention start.
|
|
Health-related quality of life
기간: < 1 week pre and 12 weeks post intervention start.
|
Change in health-related quality of life will be assessed using the Short Form Health Survey (SF-12). Weighted physical and mental component scores range from 0-100, with higher scores indicating better physical or mental health. |
< 1 week pre and 12 weeks post intervention start.
|
기타 결과 측정
기타 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Feasibility of the KREHA training (total number of training sessions)
기간: Throughout the intervention phase, week 0-12
|
Successful implementation of the KREHA training in the clinical routine, by assessing whether the 20 KREHA sessions are completed within 12 weeks. |
Throughout the intervention phase, week 0-12
|
|
Feasibility of the KREHA training progression (number of sessions adapted)
기간: Throughout the intervention phase, week 0-12
|
Feasibility of the KREHA training progression, by assessing how many training sessions needed to be adapted. |
Throughout the intervention phase, week 0-12
|
|
Feasibility of the KREHA training progression (power adaptation)
기간: Throughout the intervention phase, week 0-12
|
Feasibility of the KREHA training progression, by assessing how much the target power (in Watts) of a training session needed to be adapted compared to the initially planned progression. |
Throughout the intervention phase, week 0-12
|
공동 작업자 및 조사자
연구 기록 날짜
연구 주요 날짜
연구 시작 (추정된)
연구 시작
기본 완료 (추정된)
기본 완료
연구 완료 (추정된)
연구 완료
연구 등록 날짜
최초 제출
최초 제출
QC 기준을 충족하는 최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (실제)
처음 게시됨
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
마지막 업데이트 게시됨
QC 기준을 충족하는 마지막 업데이트 제출
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
마지막으로 확인됨
추가 정보
이 연구와 관련된 용어
기타 연구 ID 번호
기타 연구 ID 번호
- 2023-21
- SNCTP000006132 (기타 식별자: Swiss National Clinical Trials Portal)
개별 참가자 데이터(IPD) 계획
개별 참가자 데이터(IPD)를 공유할 계획입니까?
약물 및 장치 정보, 연구 문서
미국 FDA 규제 의약품 연구
미국 FDA 규제 기기 제품 연구
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .